Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit I Giasson

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
Acta Neuropathologica Communications|March 14, 2020
Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's diseaseGrace M Lloyd, Jorge A Trejo-Lopez, Yuxing Xia, et al.
Acta Neuropathologica Communications|April 20, 2022
Impact of APOE genotype on prion-type propagation of tauopathyTristan Williams, Alejandra Jolie Ruiz, Angelica Maria Ruiz, et al.
Acta Neuropathologica Communications|July 23, 2023
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesisGrace M Lloyd, Brooke Long, Stephan Quintin, et al.
ACS Chemical Neuroscience|December 26, 2022
Evaluation of an Adoptive Cellular Therapy-Based Vaccine in a Transgenic Mouse Model of α-synucleinopathyWinston T Chu, Jesse Hall, Anjela Gurrala, et al.
Neuroscience Letters|September 9, 2020
Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 proteinJorge A Trejo-Lopez, Zachary A Sorrentino, Cara J Riffe, et al.
Science Advances|November 12, 2020
Determinants of seeding and spreading of α-synuclein pathology in the brainMartin T Henrich, Fanni F Geibl, Harini Lakshminarasimhan, et al.
Acta Neuropathologica Communications|June 24, 2020
Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathiesYuxing Xia, Stefan Prokop, Kimberly-Marie M Gorion, et al.
Journal of Neurochemistry|July 31, 2003
Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitroAmanda J Mishizen-Eberz, Rodney P Guttmann, Benoit I Giasson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 31, 2020
Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative PhenotypesMarshall S Goodwin, Olga Sinyavskaya, Franklin Burg, et al.
Acta Neuropathologica|March 25, 2014
Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in miceAmanda N Sacino, Mieu Brooks, Michael A Thomas, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Acta Neuropathologica Communications|March 14, 2020
Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's diseaseGrace M Lloyd, Jorge A Trejo-Lopez, Yuxing Xia, et al.
Acta Neuropathologica Communications|April 20, 2022
Impact of APOE genotype on prion-type propagation of tauopathyTristan Williams, Alejandra Jolie Ruiz, Angelica Maria Ruiz, et al.
Acta Neuropathologica Communications|July 23, 2023
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesisGrace M Lloyd, Brooke Long, Stephan Quintin, et al.
ACS Chemical Neuroscience|December 26, 2022
Evaluation of an Adoptive Cellular Therapy-Based Vaccine in a Transgenic Mouse Model of α-synucleinopathyWinston T Chu, Jesse Hall, Anjela Gurrala, et al.
Neuroscience Letters|September 9, 2020
Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 proteinJorge A Trejo-Lopez, Zachary A Sorrentino, Cara J Riffe, et al.
Science Advances|November 12, 2020
Determinants of seeding and spreading of α-synuclein pathology in the brainMartin T Henrich, Fanni F Geibl, Harini Lakshminarasimhan, et al.
Acta Neuropathologica Communications|June 24, 2020
Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathiesYuxing Xia, Stefan Prokop, Kimberly-Marie M Gorion, et al.
Journal of Neurochemistry|July 31, 2003
Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitroAmanda J Mishizen-Eberz, Rodney P Guttmann, Benoit I Giasson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 31, 2020
Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative PhenotypesMarshall S Goodwin, Olga Sinyavskaya, Franklin Burg, et al.
Acta Neuropathologica|March 25, 2014
Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in miceAmanda N Sacino, Mieu Brooks, Michael A Thomas, et al.
Pageof 18